Monroe Capital LLC announced an increase in its credit facility to ProPharma Group to support the acquisitions of The Weinberg Group, Inc. and Southwood Research. ProPharma is an existing portfolio company of Linden Capital Partners.

MidCap Financial also participated in the transaction.
 
Based in Washington, D.C., The Weinberg Group, Inc. is a leading FDA consultancy. For over 35 years, the company has provided pharmaceutical, biotechnology, and medical device consulting services to companies of every size on every continent, supplying them with viable and efficient drug development pathways and compliance solutions.

Based in Buckinghamshire, United Kingdom, Southwood Research is a leading provider of pre-approval regulatory science services to the pharmaceutical and biotech industries. ProPharma is an international, independent, single-source provider of comprehensive compliance services that span the entire lifecycle of pharmaceuticals, biologics, and medical devices. The additions of The Weinberg Group in the United States and Southwood Research in the UK will bolster ProPharma’s regulatory affairs capabilities and represent a truly unique end-to-end global regulatory practice.